Literature DB >> 17380271

Vogt-Koyanagi-Harada disease in Hispanic patients.

Somsiri Sukavatcharin1, Julie H Tsai, Narsing A Rao.   

Abstract

PURPOSE: To describe the clinical features of Vogt-Koyanagi-Harada disease (VKH) in Hispanic patients.
METHODS: Retrospective review of the records of 48 Hispanic patients diagnosed with VKH. The patients were divided into two groups: patients in the early phase of VKH (n = 11) were those who presented within 1 month after the onset of symptoms; patients in the late or chronic VKH phase (n = 37) were those who presented 6 months after onset of symptoms. Demographic data, clinical features, complications and initial and final visual acuity for each patient were recorded.
RESULTS: All 11 patients in early phase VKH presented with bilateral uveitis (100%). Meningismus was noted in six cases and auditory disturbances in three. Ocular findings for these 11 patients included exudative retinal detachment in ten patients (91%) and marked optic disc edema in one patient. In the late phase VKH, ocular findings included sunset glow fundus in 26 patients (70%), peripheral nummular scars in 27 (73%), and retinal pigment epithelium hyperplasia in seven (19%). Extraocular manifestations noted in this group of patients included vitiligo in four, poliosis in six, and alopecia in five; auditory disturbances were found in four patients. The visual acuity improved in 60-70% of the patients after treatment with corticosteroids alone or in combination with immunosuppressive agents.
CONCLUSION: Hispanic patients with VKH often present without extraocular changes during early phase of the disease. However, once the disease evolves into the chronic phase, integumentary system involvement may become apparent in some patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380271     DOI: 10.1007/s10792-006-9017-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  20 in total

1.  Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.

Authors:  Y Sasamoto; S Ohno; H Matsuda
Journal:  Ophthalmologica       Date:  1990       Impact factor: 3.250

2.  Vogt-Koyanagi-Harada syndrome.

Authors:  S Ohno; D H Char; S J Kimura; G R O'Connor
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

3.  Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome.

Authors:  P E Rubsamen; J D Gass
Journal:  Arch Ophthalmol       Date:  1991-05

4.  Vogt-Koyanagi-Harada syndrome.

Authors:  D A Snyder; H H Tessler
Journal:  Am J Ophthalmol       Date:  1980-07       Impact factor: 5.258

5.  Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome.

Authors:  R S Moorthy; B Rajeev; R E Smith; N A Rao
Journal:  Am J Ophthalmol       Date:  1994-08-15       Impact factor: 5.258

Review 6.  Vogt-Koyanagi-Harada syndrome.

Authors:  R S Moorthy; H Inomata; N A Rao
Journal:  Surv Ophthalmol       Date:  1995 Jan-Feb       Impact factor: 6.048

7.  Clinical studies of Vogt-Koyanagi-Harada's disease.

Authors:  S Ohno; R Minakawa; H Matsuda
Journal:  Jpn J Ophthalmol       Date:  1988       Impact factor: 2.447

8.  Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.

Authors:  Hiroshi Keino; Hiroshi Goto; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-09-06       Impact factor: 3.117

9.  Subretinal fibrosis in retinal detachment.

Authors:  R H Wallyn; G F Hilton
Journal:  Arch Ophthalmol       Date:  1979-11

10.  Variations in clinical features of the Vogt-Koyanagi-Harada syndrome.

Authors:  J Beniz; D J Forster; J S Lean; R E Smith; N A Rao
Journal:  Retina       Date:  1991       Impact factor: 4.256

View more
  10 in total

1.  The spectrum of Vogt-Koyanagi-Harada disease in Iran.

Authors:  Alireza Hedayatfar; Seyedeh Maryam Hosseini; Nasser Karimi; Khalil Ghasemi Falavarjani; Negin Badie; Mahsa Zameni; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2017-03-04       Impact factor: 2.031

2.  Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina.

Authors:  Verónica E Giordano; Ariel Schlaen; Martín J Guzmán-Sánchez; Cristobal Couto
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

3.  Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.

Authors:  Sonia Attia; Sana Khochtali; Rim Kahloun; Dhiaeddine Ammous; Bechir Jelliti; Salim Ben Yahia; Sonia Zaouali; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2015-05-05       Impact factor: 2.031

Review 4.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

5.  MR imaging of Vogt-Koyanagi-Harada syndrome with leptomeningeal enhancement.

Authors:  B D Lohman; C A Gustafson; A M McKinney; B Sarikaya; S C Silbert
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

Review 6.  Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.

Authors:  Tingkun Shi; Wenjuan Lv; Li Zhang; Jianhuan Chen; Haoyu Chen
Journal:  Sci Rep       Date:  2014-11-10       Impact factor: 4.379

Review 7.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

Review 8.  Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.

Authors:  Carl P Herbort; Ahmed M Abu El Asrar; Joyce H Yamamoto; Carlos E Pavésio; Vishali Gupta; Moncef Khairallah; Ilknur Tugal-Tutkun; Masoud Soheilian; Masuru Takeuchi; Marina Papadia
Journal:  Int Ophthalmol       Date:  2016-11-14       Impact factor: 2.031

9.  Proliferative retinopathy as a feature of Vogt Koyanagi Harada Disease: a report of two cases.

Authors:  Moustafa S Magliyah; Abdulmajeed S Al-Fakhri; Hassan A Al-Dhibi
Journal:  BMC Ophthalmol       Date:  2020-12-01       Impact factor: 2.209

Review 10.  Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia.

Authors:  Yujuan Wang; Chi-Chao Chan
Journal:  J Ophthalmol       Date:  2014-03-05       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.